Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling(Ludwig-Maximilians-Universität München), Marco Ladetto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Elı́as Campo(Hospital Clínic de Barcelona), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Steven Le Gouill(Inserm), Simon Rule(AstraZeneca (United Kingdom)), Olivier Hermine(Centre National de la Recherche Scientifique), Ofer Shpilberg(Texas Oncology), Mats Jerkeman(Skåne University Hospital)
Cited by 736
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
|Blood|2011|2k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k